reference/307975

Predicate	Object
contentType	Journal Article\|Review
endingPage	732
issn	1179-1950 0012-6667
issueIdentifier	6
pageRange	725-732
publicationName	Drugs
startingPage	725
bibliographicCitation	Zimarino M, Renda G, De Caterina R. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents. Drugs. 2005;65(6):725–32. doi: 10.2165/00003495-200565060-00001. PMID: 15819586.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_053cd6d796cb3812045755909b324340 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33fde1784026839eec8c33b752b907f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97346ae585bc4921dda834a3eee0439d
date	200504
identifier	https://doi.org/10.2165/00003495-200565060-00001 https://pubmed.ncbi.nlm.nih.gov/15819586
isPartOf	https://portal.issn.org/resource/ISSN/1179-1950 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453 https://portal.issn.org/resource/ISSN/0012-6667
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents
discusses	http://id.nlm.nih.gov/mesh/M0155432 http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0001864
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7334 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298

Total number of triples: 34.